Sanara MedTech CEO Steps Down, Agrees to Severance Deal

Sanara MedTech (SMTI) has shared an announcement.

Zachary B. Fleming stepped down as CEO of Sanara MedTech Inc. on May 10, 2024, and subsequently agreed to a Separation Agreement providing him with a year’s base salary as severance, paid in installments, along with COBRA health coverage for himself and dependents during this period. Additionally, the company will allow 50% of his unvested restricted stock to continue vesting and accelerate a portion of it to cover tax obligations. In return, Fleming has committed to a general release of claims and to adhere to a non-disparagement agreement post-resignation.

For a thorough assessment of SMTI stock, go to TipRanks’ Stock Analysis page.